Intellectual Property Management

Domain Overview

Intellectual property management encompasses the strategic acquisition, prosecution, maintenance, enforcement, licensing, and valuation of patents, trademarks, trade secrets, and copyrights within an enterprise portfolio. The U.S. patent system, fundamentally reshaped by the Leahy-Smith America Invents Act (AIA) of 2011, operates under a first-inventor-to-file regime (effective March 16, 2013) codified in revised 35 USC § 102. This shift eliminated interference proceedings in favor of derivation proceedings, broadened prior art definitions to include foreign public use and on-sale activity, and introduced post-grant review (PGR) and inter partes review (IPR) as administrative patent validity challenges before the Patent Trial and Appeal Board (PTAB). In 2025, the USPTO proposed major new IPR rules under a Notice of Proposed Rulemaking (NPRM) issued October 16, 2025, restricting serial/parallel petitions and requiring mandatory stipulations against pursuing §§ 102/103 invalidity arguments in parallel forums.

Trademark protection operates under the Lanham Act (15 USC § 1051 et seq.), with the USPTO implementing significant fee increases effective January 18, 2025 — base application fees now at $350 per class for national direct filings, with $200 surcharges for free-form goods/services descriptions not using pre-approved identifications from the USPTO ID Manual. International trademark protection through the Madrid Protocol requires precise alignment between base and international applications, with Nice Classification (currently 12th Edition, 45 classes) governing goods/services categorization across 130+ member countries. Section 8 declarations of use (due between 5th-6th year post-registration, then every 10 years) and Section 9 renewal applications (every 10 years) are absolute deadlines — failure results in registration cancellation with no automatic reinstatement.

Trade secret protection gained federal standing through the Defend Trade Secrets Act (DTSA) of 2016, codified within the Economic Espionage Act at 18 USC §§ 1831-1839. The DTSA provides civil remedies for misappropriation alongside state Uniform Trade Secrets Act (UTSA) claims, but demands that owners demonstrate "reasonable measures" to maintain secrecy — a fact-intensive standard with no bright-line rule. The Seventh Circuit's 2024 decision in Motorola v. Hytera (108 F.4th) confirmed DTSA extraterritorial application where an act in furtherance of misappropriation occurs in the United States, producing a $135.8 million compensatory and $271.6 million punitive damages award based on worldwide sales. The DTSA also contains whistleblower immunity provisions (18 USC § 1833(b)) protecting disclosures made in confidence to government officials or filed under seal in litigation.

Enterprise IP management requires integration across legal, R&D, finance, and business strategy functions. The Bayh-Dole Act (35 USC §§ 200-212) governs inventions arising from federally funded research, requiring timely disclosure, election of title, and compliance with reporting obligations. In August 2025, the Department of Commerce took the unprecedented step of initiating march-in rights proceedings against Harvard University under 35 USC § 203, signaling heightened enforcement of Bayh-Dole compliance obligations that organizations receiving federal research funding cannot ignore.

Core Decision Framework

Patent Prosecution Decision Tree

Stage 1 — Invention Disclosure Triage: Evaluate each disclosure against three filters: (a) patentable subject matter under 35 USC § 101 (accounting for Alice/Mayo framework for abstract ideas and laws of nature), (b) strategic alignment with product roadmap or defensive objectives, and (c) prior art landscape assessment using patent search databases. Score each disclosure on a 1-5 scale across novelty, commercial value, enforceability, and design-around difficulty.

Stage 2 — Filing Strategy: Decide between provisional application (12-month priority window, lower cost, no examination) and non-provisional application (triggers examination, 20-year term from earliest effective filing date). For international protection, evaluate PCT (Patent Cooperation Treaty) filing within 12 months of priority date versus direct national filings. PCT provides 30/31-month national phase entry deadline. Consider continuation, continuation-in-part (CIP), and divisional strategies — noting that the USPTO now imposes a $2,700 surcharge for continuing applications filed 6+ years after earliest claimed benefit date, and $4,000 for 9+ years.

Stage 3 — Prosecution Management: Track office action deadlines (typically 3 months, extendable to 6 months with escalating extension fees from $260 to $3,140 for large entities). Evaluate each rejection type: § 101 subject matter eligibility, § 102 novelty, § 103 obviousness, § 112 written description/enablement. Avoid prosecution history estoppel by minimizing unnecessary claim amendments and specification characterizations that could narrow claim scope during enforcement.

Trademark Protection Decision Tree

Step 1 — Clearance: Conduct comprehensive search (USPTO TESS database, state registrations, common law use, domain names, social media). Evaluate likelihood of confusion under the DuPont factors (13-factor test). Assess mark strength along the Abercrombie spectrum: generic → descriptive → suggestive → arbitrary → fanciful.

Step 2 — Filing and Classification: Select appropriate Nice Classification classes covering actual and intended goods/services. Use pre-approved identifications from the USPTO ID Manual to avoid $200 surcharges per class. For intent-to-use (ITU) applications under Section 1(b), track the Statement of Use deadline (6 months from Notice of Allowance, extendable up to 36 months total with $125/class extension fees).

Step 3 — Post-Registration Maintenance: Calendar all Section 8/Section 9/Section 15 deadlines with redundant alert systems. Section 15 declarations of incontestability (filed after 5 consecutive years of use) provide significant defensive advantages by limiting cancellation grounds.

Trade Secret Protection Framework

Evaluate every claimed trade secret against the DTSA's two-pronged test: (1) independent economic value from not being generally known or readily ascertainable, and (2) reasonable measures to maintain secrecy. Document all protective measures — NDAs, access controls, encryption, visitor policies, classification markings, employee onboarding/offboarding protocols. Courts in 2024 granted summary judgment against trade secret claims where owners failed to designate materials as confidential per contractual requirements (Jacam Chem. Co. v. Shepard, 101 F.4th 954, 8th Cir. 2024).

Step-by-Step Process

Full IP Portfolio Lifecycle

Invention Capture: Implement formal invention disclosure process with standardized forms capturing inventors, conception date, first disclosure date, federal funding sources (Bayh-Dole trigger), and prior art known to inventors.
Prior Art Analysis: Conduct patentability search and freedom-to-operate (FTO) analysis before committing prosecution resources. FTO is distinct from patentability — an invention can be patentable yet infringe existing patents.
IP Committee Review: Convene cross-functional committee (IP counsel, R&D leadership, business unit heads) to evaluate disclosures against portfolio strategy. Decision outcomes: file patent, protect as trade secret, publish defensively, or decline protection.
Prosecution Execution: Draft claims with enforceability in mind — avoid patent profanity ("essential," "critical," "necessary," "key") in specifications. Maintain consistent terminology between claims and specification per Phillips v. AWH (Fed. Cir. 2005, en banc). Comply with duty of candor (37 CFR § 1.56) by disclosing all material prior art through Information Disclosure Statements (IDS).
Portfolio Maintenance: Track and pay patent maintenance fees at 3.5 years ($2,150 large entity), 7.5 years ($4,040), and 11.5 years ($8,280). Late payment within 6-month grace period incurs $540 surcharge. After grace period, reinstatement requires petition under 37 CFR § 1.378 demonstrating unintentional delay ($2,260 petition fee).
Trademark Monitoring: Implement watch services covering new USPTO applications, Madrid Protocol designations, and common law use. File opposition proceedings within 30 days of publication (extendable) at the Trademark Trial and Appeal Board (TTAB).
Trade Secret Audit: Conduct annual trade secret inventory. Verify access logs, NDA currency, departed employee protocols, and classification consistency. Update protective measures as technology and workforce evolve.
Licensing Program Management: Structure royalty provisions with unambiguous definitions of royalty base, licensed products, territory, and affiliate scope. Include audit rights with at least annual frequency. Address post-acquisition scenarios explicitly — define whether acquiror products become royalty-bearing.
Portfolio Valuation: Apply appropriate methodology — income approach (DCF of projected royalty streams), market approach (comparable transaction benchmarks), or cost approach (reproduction/replacement cost less obsolescence). Hybrid approaches triangulate across methods for higher confidence.
Annual Portfolio Review: Prune non-strategic assets (abandon, sell, or donate patents). Identify white space opportunities. Benchmark portfolio against competitor filings and industry trends.

Evaluation Criteria

Patent Application Quality Scoring (1-5 per factor)

Factor	Weight	Assessment Basis
Claim Breadth	25%	Independent claim scope relative to prior art boundary
Specification Support	20%	Written description and enablement coverage for claim permutations
Commercial Relevance	20%	Alignment with active or planned product lines
Enforceability	15%	Detectability of infringement, design-around difficulty
Prosecution Cleanliness	10%	Absence of limiting amendments and prosecution history estoppel
Remaining Term Value	10%	Years remaining weighted by technology lifecycle

Trademark Registration Strength Assessment

Distinctiveness: Abercrombie classification (fanciful/arbitrary score highest)
Registration Status: Federal registration > state registration > common law
Incontestability: Section 15 declaration filed and accepted
Use Consistency: Specimen quality, continuous use documentation
Geographic Coverage: National, international (Madrid designations), key market alignment

Trade Secret Program Maturity

Level 1 — Ad Hoc: NDAs exist but no formal inventory or classification
Level 2 — Defined: Trade secret register maintained, access controls documented
Level 3 — Managed: Annual audits conducted, employee training program active, departing-employee protocols enforced
Level 4 — Optimized: Automated access logging, real-time monitoring, threat intelligence integration, incident response plan tested

Red Flags & Edge Cases

Missed Maintenance Fee with Intervening Rights: Patent expires due to non-payment, third party begins manufacturing during lapse period. Even after reinstatement under 37 CFR § 1.378, the third party acquires intervening rights under 35 USC § 41(c)(2), permitting continued use — the patent holder cannot enforce against activity that began during the lapse.
Central Attack on Madrid Registration: If the home-country base trademark registration is cancelled or narrowed within five years of international registration (the "dependency period"), all Madrid Protocol designations derived from that base are also cancelled ("central attack" under Article 6(3) of the Madrid Protocol). Organizations must maintain the base registration during this period.
Prosecution History Estoppel from Careless Office Action Responses: Characterizing prior art references as teaching specific limitations — even when unnecessary for overcoming the rejection — creates estoppel that narrows claims during enforcement. Per Festo Corp. v. Shoketsu Kinzoku (S. Ct. 2002), claim amendments made to satisfy patentability carry a presumption of prosecution history estoppel.
Trade Secret Destruction Through Inadequate Exit Interviews: Former employee takes customer lists, pricing algorithms, or source code. In BlueLinx Corp. v. Edwards (N.D. Tex. 2024), the court examined whether the employer had adequate departure protocols. Failure to conduct documented exit interviews, collect devices, and terminate access within 24 hours undermines "reasonable measures" claims.
Bayh-Dole Non-Compliance Triggering March-In Rights: Organizations receiving federal research funding that fail to timely disclose inventions (within 2 months of inventor notification to IP counsel, then within specified agency timelines), elect title (within 2 years of disclosure), or file patent applications (within 1 year of election) risk government seizure of title under 35 USC § 202(c) — as demonstrated by the Commerce Department's August 2025 action against Harvard.
Royalty Stacking in Multi-Patent Licenses: Licensee agrees to royalties on multiple patent families covering a single product without negotiating aggregate caps. When 5-8 patent families each carry 2-4% royalty rates, the effective cumulative royalty renders the product commercially unviable. Always negotiate royalty stacking caps and anti-royalty-stacking provisions.
ITU Application Abandonment from Statement of Use Deadline Miss: Intent-to-use trademark application receives Notice of Allowance, but the 6-month SOU deadline (and extension request deadlines) are missed because the docketing system only tracked the initial filing date, not the NOA date. The application goes abandoned with no reinstatement right.
Joint Inventor Disputes Clouding Patent Title: Under 35 USC § 262, each joint inventor owns an undivided interest in the entire patent and may license it without consent of co-inventors, absent an agreement to the contrary. Failure to execute assignment agreements before filing creates situations where a departed co-inventor licenses competitors.
DTSA Whistleblower Immunity Scope Creep: Employee retains thousands of company documents under the guise of whistleblower protection (18 USC § 1833(b)), but immunity only covers disclosures made in confidence to government officials or under seal in litigation — not wholesale document retention. Per Thermo Fisher Sci. v. Arthur (E.D. Mo. 2023), blanket retention claims are rejected.
Trademark Genericide from Uncontrolled Licensee Usage: Brand name used as a generic noun/verb by licensees in marketing materials without trademark designations (®/™) or proper attribution. Once a mark becomes generic through failure to police usage, registration is subject to cancellation — historical examples include escalator, aspirin, and thermos.
Design Patent vs. Utility Patent Misalignment: Filing only utility patents for innovations where the commercial differentiator is ornamental appearance, or filing only design patents where the value lies in functional methodology. Design patents have 15-year terms (from grant), no maintenance fees, but protect only ornamental appearance — not function.
Patent Term Adjustment (PTA) vs. Patent Term Extension (PTE) Miscalculation: PTA compensates for USPTO delays during prosecution (35 USC § 154(b)); PTE compensates for regulatory review delays for drugs/medical devices (35 USC § 156). Errors in calculating or challenging PTA can leave years of patent term unrealized. The applicant must file PTA disputes within 180 days of grant.

Common Mistakes

Treating IP as a legal function only: Effective IP management requires strategic integration with R&D, product, and business development. Legal-only portfolios accumulate patents that protect nothing the company actually sells.
Filing patents without FTO analysis: Companies patent their own technology but fail to analyze whether their products infringe others' patents. Patentability and freedom-to-operate are independent inquiries.
Inconsistent claim terminology: Using "motor" in one claim and "drive mechanism" in another when referring to the same element creates ambiguity during prosecution and enforcement. Per Phillips v. AWH, the specification is the "single best guide" to claim meaning.
Over-relying on provisional applications: Provisionals establish priority dates but expire after 12 months. Teams file provisionals and then fail to file non-provisional conversions on time, losing priority permanently.
Inadequate specimen evidence for trademark use: Filing Section 8 declarations with specimens that show the mark used differently from the registration (different design, different goods/services) results in rejection or cancellation.
Failing to define "Net Revenue" in license agreements: Ambiguous royalty base definitions create disputes. Licensees deduct shipping, returns, taxes, and sometimes R&D costs — every deduction must be explicitly included or excluded in the agreement.
No trade secret inventory: Organizations claim trade secret protection in litigation but cannot produce a pre-existing register identifying what was protected, when, and how. Courts view after-the-fact identification skeptically.
Ignoring the DTSA employer notification requirement: Under 18 USC § 1833(b)(3), employers must provide notice of whistleblower immunity in any contract governing trade secrets or confidential information. Failure to include this notice bars recovery of exemplary damages and attorney fees under the DTSA.
Single-point-of-failure docketing: Relying on one paralegal's calendar or a single spreadsheet for patent/trademark deadlines. Missed deadlines cause irreversible loss of rights. Enterprise-grade docketing systems with redundant alerts are a baseline requirement.
Neglecting post-issuance monitoring for IPR threats: Not tracking third-party IPR petitions against portfolio patents. Under current rules, patent owners have limited time to respond, and the proposed 2025 NPRM rules introduce new stipulation requirements that demand prompt strategic decisions.

Regulatory & Compliance Requirements

Federal Patent Law

35 USC §§ 101-103: Patentable subject matter, novelty (first-to-file), non-obviousness
35 USC § 112: Written description, enablement, definiteness, best mode
35 USC § 154(b): Patent term adjustment for USPTO prosecution delays
37 CFR § 1.56: Duty of candor and good faith — obligation to disclose material prior art
37 CFR § 1.378: Petition for delayed maintenance fee payment (unintentional delay standard)
35 USC §§ 311-319: Inter partes review proceedings; October 2025 NPRM proposing restrictions on serial/parallel petitions
35 USC §§ 321-329: Post-grant review (within 9 months of grant, any invalidity ground)

Federal Trademark Law (Lanham Act)

15 USC § 1051 (Section 1): Application basis — use in commerce (1(a)) or intent-to-use (1(b))
15 USC § 1058 (Section 8): Declaration of continued use (years 5-6, then every 10 years)
15 USC § 1059 (Section 9): Renewal application (every 10 years)
15 USC § 1065 (Section 15): Declaration of incontestability (after 5 consecutive years of use)
15 USC § 1125(a) (Section 43(a)): Unfair competition and false designation of origin

Trade Secret Law

18 USC §§ 1836-1839 (DTSA): Federal civil cause of action for trade secret misappropriation
18 USC § 1832: Criminal theft of trade secrets (up to 10 years imprisonment)
18 USC § 1833(b): Whistleblower immunity provisions
18 USC § 1837: Extraterritorial application (confirmed by Motorola v. Hytera, 7th Cir. 2024)
Uniform Trade Secrets Act (UTSA): Adopted in 48 states plus D.C.; state-specific variations exist

Government-Funded Research

35 USC §§ 200-212 (Bayh-Dole Act): Contractor retention of title to federally funded inventions
35 USC § 202(c)(1): Disclosure obligations (timely disclosure to funding agency)
35 USC § 203: March-in rights (agency may compel licensing if commercialization criteria unmet)
37 CFR Part 401: Implementing regulations; 37 CFR § 401.14 standard patent rights clause

International Framework

Patent Cooperation Treaty (PCT): International filing with 30/31-month national phase entry
Madrid Protocol: International trademark registration system; 5-year dependency period
Nice Classification (12th Ed.): 45 classes for goods/services trademark classification
Paris Convention: 12-month patent priority, 6-month trademark priority from first filing
Hague Agreement: International design registration system

Terminology

Prosecution History Estoppel: Doctrine preventing a patent holder from recapturing claim scope surrendered during prosecution through amendments or arguments; applied under the doctrine of equivalents per Festo Corp. v. Shoketsu Kinzoku (2002).
Inter Partes Review (IPR): Administrative proceeding before the PTAB allowing any person to challenge patent validity on §§ 102/103 grounds using patents and printed publications only; must be filed after 9-month PGR window or post-grant.
Information Disclosure Statement (IDS): Filing under 37 CFR § 1.97-1.98 through which applicants satisfy their duty of candor by disclosing known material prior art to the USPTO during prosecution.
Nice Classification: International system managed by WIPO that categorizes goods (Classes 1-34) and services (Classes 35-45) for trademark registration purposes; currently in its 12th edition.
Central Attack: Vulnerability of Madrid Protocol international registrations during the 5-year dependency period; if the home-country base registration is cancelled, all international designations derived from it are also cancelled.
Continuation Application: Patent application filed claiming priority to a parent application's filing date, containing claims not present in the parent; enables pursuing alternative claim scope on the same disclosure.
Section 8 Declaration: Sworn statement filed with the USPTO between years 5-6 (and every 10 years thereafter) affirming continued use of a registered trademark in commerce; failure to file results in cancellation.
Reasonable Measures (DTSA): Fact-intensive standard under 18 USC § 1836 requiring trade secret owners to demonstrate affirmative steps to maintain secrecy — NDAs, access controls, encryption, employee training, physical security.
Freedom-to-Operate (FTO) Analysis: Assessment of whether commercializing a product or process would infringe valid, enforceable third-party IP rights; distinct from and complementary to patentability analysis.
Royalty Base: The unit or revenue amount upon which a royalty rate is calculated in a licensing agreement; in multi-component products, disputes often arise over whether the base is the component value or the entire end-product value (smallest salable patent-practicing unit doctrine).
Patent Term Adjustment (PTA): Additional patent term awarded under 35 USC § 154(b) to compensate for USPTO delays during prosecution (Type A: 14-month response delays; Type B: 3-year overall prosecution delay; Type C: interference/secrecy order delays).
Claim Chart: Document mapping each element of a patent claim to corresponding features in an accused product or prior art reference; essential tool in both enforcement and invalidity analysis.
March-In Rights: Government authority under 35 USC § 203 to compel licensing of patents arising from federally funded research if the patent holder fails to achieve practical application or satisfy health/safety needs.
Abercrombie Spectrum: Classification of trademark distinctiveness from weakest to strongest: generic (unprotectable) → descriptive (protectable only with secondary meaning) → suggestive → arbitrary → fanciful (strongest protection).
Post-Grant Review (PGR): PTAB proceeding available within 9 months of patent grant that allows challenges on any invalidity ground (including §§ 101, 112), broader than IPR which is limited to §§ 102/103 with patents/publications.
Provisional Application: Placeholder patent filing under 35 USC § 111(b) establishing a priority date without triggering examination or the 20-year patent term; expires after 12 months if not converted to a non-provisional application.
Trade Dress: Non-functional, distinctive visual appearance of a product or its packaging that serves as a source identifier; protectable under 15 USC § 1125(a) when it has acquired secondary meaning (or is inherently distinctive for product packaging).
Intervening Rights: Rights acquired by third parties who begin making, using, or selling a patented invention during a period when the patent was expired or its claims were amended; codified in 35 USC § 252 (reissue) and § 41(c)(2) (maintenance fee lapse).
Duty of Candor: Obligation under 37 CFR § 1.56 requiring all individuals substantively involved in patent prosecution (inventors, attorneys, agents) to disclose material information to the USPTO; breach can render patent unenforceable through inequitable conduct.
Specimen of Use: Evidence submitted to the USPTO demonstrating actual use of a trademark in commerce in connection with the identified goods or services; required at registration, Section 8 declarations, and Section 9 renewals.
Prior User Rights: Defense under AIA-amended 35 USC § 273 available to parties who commercially used a patented invention at least one year before the patent's effective filing date or public disclosure date; limited to the scope and volume of the prior use.
Patent Prosecution Highway (PPH): Bilateral agreements between patent offices allowing applicants whose claims are found patentable in one office to request accelerated examination in another; reduces prosecution costs and timeline.

Quality Checklist

Docketing Integrity: Verify all patent maintenance fee windows (3.5/7.5/11.5 years), trademark Section 8/9/15 deadlines, and PCT national phase entry dates are calendared with at least three redundant reminder triggers (60 days, 30 days, 7 days).
Assignment Chain: Confirm unbroken chain of title from each named inventor to the entity that owns and enforces the patent. Check that assignments are recorded at the USPTO (37 CFR § 3.11). Unrecorded assignments create standing issues in litigation.
IDS Compliance: Verify all known material prior art has been disclosed via IDS during prosecution. Cross-reference against FTO searches, opposition proceedings, and IPR petitions involving related technology. Undisclosed references are ammunition for inequitable conduct defenses.
Trade Secret Register Currency: Confirm trade secret inventory was updated within the last 12 months, that each entry has an assigned custodian, documented access controls, and current NDA coverage for all individuals with access.
Licensing Agreement Audit Provisions: Verify every active license includes: defined royalty base and calculation methodology, audit rights (frequency, scope, cost allocation), affiliate/acquiror scope provisions, and termination triggers for uncured breach.
Trademark Specimen Accuracy: For each upcoming Section 8 or Section 9 filing, confirm that specimens show the mark as registered, used in connection with the goods/services listed in the registration, in actual commerce — not mock-ups, internal documents, or altered versions.
Entity Status Verification: Confirm correct entity status (large/small/micro) for all USPTO filings. False assertions of small or micro entity status carry statutory penalties (35 USC § 257), and the USPTO introduced enhanced enforcement for false status assertions in 2025.
Bayh-Dole Compliance Tracker: For organizations receiving federal research funding, verify invention disclosure timelines, title election documentation, patent filing deadlines, and government-use license acknowledgments are current.
International Portfolio Alignment: Validate that patent family filings and Madrid Protocol trademark designations cover all commercially significant jurisdictions. Check for dependency period risks on Madrid registrations under 5 years old.
FTO Gap Analysis: Confirm FTO analysis has been conducted or updated for every product currently in market or within 12 months of launch. FTO should cover the specific commercial embodiment, not just the patented invention.
Prosecution File Wrapper Review: Audit a random sample of recently prosecuted applications for prosecution history estoppel risks — unnecessary amendments, overly narrow arguments, and specification characterizations that could limit enforcement scope.
Exit Interview Documentation: Verify that departing employees with access to trade secrets have completed documented exit interviews, returned all company devices and documents, acknowledged continuing confidentiality obligations, and had access credentials revoked within 24 hours.
License Revenue Reconciliation: For all inbound and outbound licenses, reconcile reported royalties against independently verifiable revenue data. Flag discrepancies exceeding 5% for audit consideration.
Watch Service Coverage: Confirm trademark watch services monitor USPTO applications, Madrid Protocol designations, key international registries, domain name registrations, and social media platforms for confusingly similar marks.

References

USPTO Consolidated Patent Laws — July 2025 Update: https://www.uspto.gov/web/offices/pac/mpep/consolidated_laws.pdf
USPTO Consolidated Patent Rules — July 2025 Update: https://www.uspto.gov/web/offices/pac/mpep/consolidated_rules.pdf
USPTO Fee Schedule — Effective January 19, 2025: https://www.uspto.gov/learning-and-resources/fees-and-payment/uspto-fee-schedule
USPTO Proposes New IPR Rules for Patent Challenges in 2025: https://jurislawgroup.com/uspto-proposes-new-ipr-rules-for-patent-challenges-in-2025/
2025 USPTO Recap — Patent Prosecution Changes: https://wolfgreenfield.com/articles/2025-uspto-recap-what-this-years-developments-mean-for-patent-filers
A Seismic Shift at the USPTO — IP Watchdog: https://ipwatchdog.com/2025/12/21/seismic-shift-uspto-what-happened-2025/
Trade Secrets: What You Should Know From 2024 — McGuireWoods: https://www.mcguirewoods.com/client-resources/alerts/2025/1/trade-secrets-what-you-should-know-from-2024-to-prepare-for-2025/
2024: A Year of Trade Secret Cases in Review — Finnegan: https://www.finnegan.com/en/insights/articles/2024-a-year-of-trade-secret-cases-in-review.html
What You Need to Know About Trade Secrets in 2024 — James Pooley: https://pooley.com/what-you-need-to-know-about-trade-secrets-in-2024/
2024 Trade Secret Update: Whistleblower Protections — WilmerHale: https://www.wilmerhale.com/en/insights/client-alerts/20240604-2024-trade-secret-update-whistleblower-protections-in-the-northern-district-of-california
Global Trade Secret Update 2024 — Jones Day: https://www.jonesday.com/-/media/files/publications/2025/02/global-trade-secret-update-key-developments-in-2024/
Trade Mark Laws and Regulations USA 2025-2026 — ICLG: https://iclg.com/practice-areas/trade-marks-laws-and-regulations/usa
New USPTO Fee Schedule Effective January 18, 2025 — Marshall Gerstein: https://www.marshallip.com/insights/new-uspto-fee-schedule-effective-january-18-2025/
Patent Maintenance Annuity Payments in the US — Chambers: https://chambers.com/articles/patent-maintenance-annuity-payments-in-the-united-states-a-guide-to-maintaining-patent-rights
2025 Patent Filing Costs Rise — Dickinson Wright: https://www.dickinson-wright.com/news-alerts/blog-arndt-uspto-2025-patent-fee-increases
Madrid Protocol Filing Common Mistakes — USPTO Webinar: https://www.uspto.gov/sites/default/files/documents/Madrid-Protocol-Webinar-slidesJune92020.pdf
Top Reasons Madrid Protocol Applications Get Rejected — PatentPC: https://patentpc.com/blog/top-reasons-madrid-protocol-applications-get-rejected-and-how-to-fix-them
Section 8 and 9 Trademark Renewal & Maintenance — Wilson Legal Group: https://www.wilsonlegalgroup.com/blogs/trademark-law/trademark-renewal-and-maintenance
USPTO Trademark Maintenance Definitions: https://www.uspto.gov/trademarks/maintain/forms-file/definitions-maintaining-trademark
Best Practices in Structuring Royalties — Freshfields: https://blog.freshfields.us/post/102mmjq/best-practices-in-structuring-royalties-in-license-collaboration-agreements
10 Key IP Licensing Agreement Terms — San Jose Business Lawyers: https://www.sanjosebusinesslawyersblog.com/10-key-intellectual-property-ip-licensing-agreement-terms-what-terms-do-you-need-in-your-licensing-agreement/
America Invents Act FAQ — USPTO: https://www.uspto.gov/patents/laws/america-invents-act-aia/america-invents-act-aia-frequently-asked
Navigating Bayh-Dole Compliance in 2025 — Foley Hoag: https://foleyhoag.com/news-and-insights/publications/alerts-and-updates/2025/december/navigating-bayh-dole-compliance-in-2025-risk-and-risk-mitigation-strategies/
Bayh-Dole Act and March-In Rights — Congressional Research Service: https://www.congress.gov/crs-product/IF12582
IP Valuation Approaches and Methods — LESI: https://lesi.org/wp-content/uploads/2024/04/intellectual-property-valuation-approaches-and-methods.pdf
Common Pitfalls in Drafting and Prosecuting Patent Applications — WIPO: https://www.wipo.int/edocs/mdocs/aspac/en/wipo_ip_bkk_19/wipo_ip_bkk_19_p_3.pdf
Ten Common Patent Claim Drafting Mistakes — IP Watchdog: https://ipwatchdog.com/2021/10/20/ten-common-patent-claim-drafting-mistakes-avoid/
IP Portfolio Audit Best Practices — Computer Packages: https://www.computerpackages.com/why-ip-portfolio-audit/

intellectual-property-management